You are here

  • Home
  • Archive
  • Volume 9, Issue 4
  • Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

 

Online download statistics by month:

Online download statistics by month: April 2021 to June 2025

AbstractFullPdf
Apr 2021770772337
May 2021420420128
Jun 2021241242109
Jul 202132832864
Aug 202118218262
Sep 202114714748
Oct 202114614649
Nov 202118618752
Dec 202113613633
Jan 202213514954
Feb 20229810425
Mar 202216918279
Apr 202218319087
May 2022163172106
Jun 202218119267
Jul 202217718376
Aug 202211812063
Sep 202213113762
Oct 202214314878
Nov 202212312371
Dec 2022999937
Jan 202316116342
Feb 202321121491
Mar 202313914033
Apr 2023798065
May 202312012055
Jun 2023939345
Jul 2023959646
Aug 2023888842
Sep 2023949442
Oct 202312812866
Nov 202312312338
Dec 202314714836
Jan 20247777104
Feb 2024989852
Mar 2024111113124
Apr 2024979861
May 2024646543
Jun 2024797941
Jul 2024959733
Aug 2024585726
Sep 2024899739
Oct 2024727349
Nov 2024777927
Dec 202412513050
Jan 2025747654
Feb 202510110162
Mar 202512212263
Apr 202511711741
May 2025767751
Jun 2025838328
Total736974853236